Results 201 to 210 of about 357,951 (342)

The influence of ROS1 fusion partners and resistance mechanisms in ROS1‐TKI‐treated non‐small cell lung cancer patients

Molecular Oncology, EarlyView.
This real‐world study of ROS1+ NSCLC highlights fusion diversity, treatment outcomes with crizotinib and lorlatinib, and in vitro experiments with resistance mechanisms. G2032R drives strong resistance to ROS1‐targeted TKIs, especially lorlatinib. Fusion partner location does not affect overall survival to crizotinib or lorlatinib. Findings support the
Fenneke Zwierenga, Christa Dijkhuizen, Patrick Korthuis, Wim Timens, Harry Groen, Jeroen Hiltermann, Anke van den Berg, Lyndsay Drayer, Anthonie van der Wekken   +8 more
wiley   +1 more source

Metal artifact reduction algorithm with conditional latent diffusion model for dental cone-beam CT. [PDF]

J Appl Clin Med Phys
Choi DI, Yun S, Hyun S, Cho S.
europepmc   +1 more source

Phantom Type Afterbody-Drag at Subsonic Reheat Unlit Cruise Condition

, 1971
Shigenori ANDO, Hidehiko Nishiwaki
openalex   +2 more sources

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source

Chronic phantom pain as a rare phenomenon after gender-affirming surgery: a systematic comparison study. [PDF]

Pain Rep
Schlisio B, Kugel A, Grasshoff C.
europepmc   +1 more source

A PRELIMINARY ATTEMPT TOWARD THE DEVELOPMENT OF A BREAST PHANTOM FOR EVALUATION OF MAMMOGRAPHY TECHNIQUES

, 1976
Nobuo Sato
openalex   +2 more sources

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

Spinal Cord Stimulation Therapy for Phantom Limb Pain in the Left Lower Extremity 30 Years After Onset. [PDF]

Cureus
Sasaki M, Date H, Ito H.
europepmc   +1 more source

Nature of phantoms

, 1978
Theodore L. Dorpat
openalex   +1 more source

Phantom risk: Scientific inference and the law [PDF]

, 1994
Jerome O. Nriagu
openalex   +1 more source